China NMPA Drug Inspection - Shanxi Kangyi Hengtai Pharmaceutical Co., Ltd. - Sea Breeze Vine
China NMPA drug inspection for Shanxi Kangyi Hengtai Pharmaceutical Co., Ltd. published November 28, 2017. Drug: Sea Breeze Vine. On November 28, 2017, the Shaanxi Provincial Food and Drug Administration published an announcement detailing findings f
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Shanxi Kangyi Hengtai Pharmaceutical Co., Ltd. published November 28, 2017. Drug: Sea Breeze Vine. On November 28, 2017, the Shaanxi Provincial Food and Drug Administration published an announcement detailing findings f
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox